Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bahra

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Cancers|December 11, 2022
Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null MiceSebastian Knitter, Gregor Duwe, Anika Sophie Beierle, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 28, 2016
Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantationRosa Bianca Schmuck, Anja Reutzel-Selke, Nathanael Raschzok, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Oncotarget|July 26, 2018
Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinomaGeorgi Atanasov, Corinna Dietel, Linda Feldbrügge, et al.
Gut|February 5, 2021
Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjectsM Gordian Adam, Georg Beyer, Nicole Christiansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 TrialMarianne Sinn, Bruno V Sinn, Denise Treue, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 28, 2014
Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancerAndreas Andreou, Luca Viganò, Giuseppe Zimmitti, et al.
Gastrointestinal Endoscopy|September 5, 2018
EUS-guided drainage in the management of postoperative pancreatic leaks and fistulas (with video)Christian Jürgensen, Marius Distler, Alexander Arlt, et al.
Scientific Reports|April 14, 2026
Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer modelsFlorian Doelvers, Katharina Wansch, Anna Kuehn, et al.
Cancer Medicine|December 30, 2025
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational StudyKatharina Wansch, François Schneider, Florian Dölvers, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Cancers|December 11, 2022
Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null MiceSebastian Knitter, Gregor Duwe, Anika Sophie Beierle, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 28, 2016
Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantationRosa Bianca Schmuck, Anja Reutzel-Selke, Nathanael Raschzok, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Oncotarget|July 26, 2018
Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinomaGeorgi Atanasov, Corinna Dietel, Linda Feldbrügge, et al.
Gut|February 5, 2021
Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjectsM Gordian Adam, Georg Beyer, Nicole Christiansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 TrialMarianne Sinn, Bruno V Sinn, Denise Treue, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 28, 2014
Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancerAndreas Andreou, Luca Viganò, Giuseppe Zimmitti, et al.
Gastrointestinal Endoscopy|September 5, 2018
EUS-guided drainage in the management of postoperative pancreatic leaks and fistulas (with video)Christian Jürgensen, Marius Distler, Alexander Arlt, et al.
Scientific Reports|April 14, 2026
Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer modelsFlorian Doelvers, Katharina Wansch, Anna Kuehn, et al.
Cancer Medicine|December 30, 2025
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational StudyKatharina Wansch, François Schneider, Florian Dölvers, et al.
Pageof 18